Mumps in prison: description of an outbreak in Manitoba, Canada

Andrew Walkty1, Paul Van Caeseele, Tim Hilderman

  • 1Department of Medicine, Health Sciences Centre, Winnipeg, MB. awalkty@mts.net

Abstract

Insights

A mumps outbreak in a Canadian correctional facility was successfully managed using infection control measures and vaccination. This highlights the potential benefit of a second mumps vaccine dose for inmates, similar to dormitory residents.

Area of Science:

  • Epidemiology
  • Infectious Disease Control
  • Public Health in Correctional Settings

Background:

  • Limited data exists on managing mumps outbreaks within correctional facilities.
  • Correctional centers present unique challenges for infectious disease control due to population density.

Purpose of the Study:

  • To describe the management of a mumps outbreak in a Canadian medium-security correctional center.
  • To evaluate the effectiveness of implemented control strategies.

Main Methods:

  • Adopted a standard case definition for mumps.
  • Utilized cell culture, polymerase chain reaction (PCR), and serology for case confirmation.
  • Implemented cohorting, education, transfer deferral, and monitoring for outbreak control.

Main Results:

  • Identified five confirmed mumps cases at Milner Ridge Correctional Centre and additional cases at a second facility.
  • Outbreak control involved unit cohorting, mumps education, restricted transfers, and case monitoring.
  • Vaccination was offered to inmates and staff, assuming most inmates had received only one dose previously.

Conclusions:

  • Mumps outbreaks in correctional settings can be contained with tailored infection control measures and vaccination.
  • Inmates, due to age demographics and living conditions, may benefit from a second mumps vaccine dose as primary prophylaxis.
  • This study underscores the importance of vaccination strategies in preventing infectious disease spread in closed populations.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...